| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 10 | 2015 | 140 | 2.240 |
Why?
|
| Abnormalities, Multiple | 5 | 2013 | 232 | 1.240 |
Why?
|
| Heart Defects, Congenital | 8 | 2022 | 351 | 1.170 |
Why?
|
| Respiration, Artificial | 3 | 2015 | 334 | 0.800 |
Why?
|
| Infant | 24 | 2022 | 3047 | 0.740 |
Why?
|
| Parenchymal Tissue | 1 | 2020 | 6 | 0.730 |
Why?
|
| Pulmonary Artery | 4 | 2013 | 306 | 0.720 |
Why?
|
| Pleura | 1 | 2020 | 30 | 0.720 |
Why?
|
| Infant, Newborn | 21 | 2022 | 2379 | 0.690 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2020 | 235 | 0.570 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2022 | 67 | 0.560 |
Why?
|
| Child, Preschool | 16 | 2020 | 3613 | 0.560 |
Why?
|
| Aneurysm | 3 | 2007 | 58 | 0.550 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2012 | 148 | 0.550 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 2013 | 72 | 0.530 |
Why?
|
| Heart-Assist Devices | 4 | 2015 | 731 | 0.500 |
Why?
|
| Cineangiography | 1 | 2013 | 13 | 0.480 |
Why?
|
| Tracheobronchomalacia | 1 | 2013 | 11 | 0.470 |
Why?
|
| Vascular Malformations | 1 | 2013 | 19 | 0.470 |
Why?
|
| Atrial Appendage | 1 | 2013 | 26 | 0.460 |
Why?
|
| Retrospective Studies | 21 | 2022 | 8496 | 0.460 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2013 | 14 | 0.450 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2012 | 5 | 0.430 |
Why?
|
| Lactates | 2 | 2022 | 37 | 0.420 |
Why?
|
| Heart Block | 1 | 2012 | 32 | 0.420 |
Why?
|
| Heart Transplantation | 3 | 2015 | 705 | 0.420 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2010 | 64 | 0.390 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2012 | 187 | 0.380 |
Why?
|
| Child | 15 | 2022 | 6928 | 0.360 |
Why?
|
| Expectorants | 1 | 2009 | 6 | 0.350 |
Why?
|
| Deoxyribonucleases | 1 | 2009 | 27 | 0.350 |
Why?
|
| Pulmonary Atelectasis | 1 | 2009 | 18 | 0.350 |
Why?
|
| Registries | 1 | 2013 | 703 | 0.340 |
Why?
|
| Patient Transfer | 1 | 2010 | 91 | 0.340 |
Why?
|
| Aorta | 2 | 2007 | 281 | 0.330 |
Why?
|
| Heart Failure | 2 | 2015 | 1204 | 0.330 |
Why?
|
| Treatment Outcome | 15 | 2022 | 7998 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 2601 | 0.300 |
Why?
|
| Female | 28 | 2020 | 44550 | 0.290 |
Why?
|
| Tetralogy of Fallot | 2 | 2012 | 44 | 0.290 |
Why?
|
| Humans | 41 | 2023 | 86678 | 0.280 |
Why?
|
| Critical Care | 1 | 2009 | 370 | 0.270 |
Why?
|
| Pulmonary Atresia | 2 | 2004 | 12 | 0.260 |
Why?
|
| Ductus Arteriosus | 2 | 2006 | 26 | 0.260 |
Why?
|
| Decision Making | 1 | 2010 | 642 | 0.240 |
Why?
|
| Time Factors | 7 | 2015 | 5214 | 0.240 |
Why?
|
| Hemodynamics | 5 | 2022 | 711 | 0.240 |
Why?
|
| Male | 23 | 2015 | 40988 | 0.230 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2023 | 15 | 0.230 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2023 | 32 | 0.220 |
Why?
|
| Arteriovenous Malformations | 1 | 2023 | 41 | 0.220 |
Why?
|
| Norwood Procedures | 1 | 2022 | 35 | 0.220 |
Why?
|
| Sodium Bicarbonate | 1 | 2022 | 10 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2013 | 462 | 0.210 |
Why?
|
| Follow-Up Studies | 6 | 2015 | 3642 | 0.210 |
Why?
|
| Cohort Studies | 5 | 2015 | 2768 | 0.200 |
Why?
|
| Gestational Age | 4 | 2013 | 311 | 0.190 |
Why?
|
| Propranolol | 2 | 2010 | 45 | 0.180 |
Why?
|
| Cough | 1 | 2020 | 54 | 0.180 |
Why?
|
| Hemangioma | 2 | 2010 | 60 | 0.180 |
Why?
|
| Dyspnea | 1 | 2020 | 73 | 0.170 |
Why?
|
| Fibrosis | 1 | 2020 | 203 | 0.170 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2010 | 152 | 0.170 |
Why?
|
| Ultrasonography | 5 | 2013 | 695 | 0.160 |
Why?
|
| Adolescent | 7 | 2010 | 8984 | 0.160 |
Why?
|
| Rhabdomyoma | 1 | 1998 | 2 | 0.160 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2012 | 191 | 0.160 |
Why?
|
| Echocardiography | 5 | 2010 | 911 | 0.150 |
Why?
|
| Heart Neoplasms | 1 | 1998 | 62 | 0.150 |
Why?
|
| Heart Ventricles | 2 | 2022 | 760 | 0.150 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 244 | 0.140 |
Why?
|
| Neuroblastoma | 1 | 2020 | 375 | 0.140 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 37 | 0.130 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2015 | 49 | 0.130 |
Why?
|
| Antithrombin III | 1 | 2014 | 9 | 0.120 |
Why?
|
| Antithrombins | 1 | 2014 | 12 | 0.120 |
Why?
|
| Cardiac Catheterization | 2 | 2010 | 291 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 1673 | 0.120 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2013 | 54 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 263 | 0.110 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2013 | 10 | 0.110 |
Why?
|
| Cyanosis | 1 | 2012 | 9 | 0.110 |
Why?
|
| Heparin | 1 | 2014 | 175 | 0.110 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 30 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 213 | 0.110 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2015 | 187 | 0.110 |
Why?
|
| Heart Septum | 1 | 2012 | 45 | 0.110 |
Why?
|
| Cause of Death | 1 | 2014 | 277 | 0.110 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 144 | 0.110 |
Why?
|
| Femoral Vein | 1 | 2012 | 35 | 0.110 |
Why?
|
| Ketamine | 1 | 2012 | 24 | 0.110 |
Why?
|
| Critical Illness | 2 | 2012 | 294 | 0.100 |
Why?
|
| Jugular Veins | 1 | 2012 | 69 | 0.100 |
Why?
|
| Femoral Artery | 1 | 2012 | 81 | 0.100 |
Why?
|
| Risk Factors | 2 | 2015 | 5420 | 0.100 |
Why?
|
| Respiration | 1 | 2013 | 262 | 0.100 |
Why?
|
| Peritoneal Dialysis | 1 | 2012 | 32 | 0.100 |
Why?
|
| Hepacivirus | 1 | 2013 | 160 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2013 | 126 | 0.100 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 94 | 0.100 |
Why?
|
| Survival Analysis | 3 | 2012 | 1538 | 0.100 |
Why?
|
| Regression Analysis | 2 | 2010 | 596 | 0.100 |
Why?
|
| Career Choice | 1 | 2013 | 142 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2012 | 64 | 0.100 |
Why?
|
| Hospital Mortality | 2 | 2012 | 350 | 0.100 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 916 | 0.100 |
Why?
|
| Carotid Arteries | 1 | 2012 | 127 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 107 | 0.100 |
Why?
|
| Survival Rate | 3 | 2009 | 1864 | 0.100 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 23 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2014 | 408 | 0.090 |
Why?
|
| Hospitals, Special | 1 | 2010 | 7 | 0.090 |
Why?
|
| Length of Stay | 3 | 2022 | 704 | 0.090 |
Why?
|
| Tracheal Neoplasms | 1 | 2009 | 8 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2012 | 161 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2438 | 0.090 |
Why?
|
| Lymphopenia | 1 | 2009 | 28 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 339 | 0.090 |
Why?
|
| Fetal Heart | 1 | 2009 | 13 | 0.090 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2009 | 31 | 0.090 |
Why?
|
| Pulmonary Ventilation | 1 | 2009 | 32 | 0.090 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2010 | 99 | 0.090 |
Why?
|
| Biomarkers | 4 | 2022 | 1718 | 0.090 |
Why?
|
| Anesthesia, General | 1 | 2010 | 114 | 0.080 |
Why?
|
| Contrast Media | 1 | 2013 | 1078 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2010 | 297 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 185 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2015 | 2264 | 0.080 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2007 | 9 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2007 | 234 | 0.080 |
Why?
|
| Biliary Atresia | 1 | 2007 | 22 | 0.080 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 54 | 0.080 |
Why?
|
| Chromosome Aberrations | 1 | 2009 | 387 | 0.080 |
Why?
|
| Neutrophils | 1 | 2009 | 307 | 0.080 |
Why?
|
| Vena Cava, Superior | 1 | 2007 | 59 | 0.070 |
Why?
|
| Fontan Procedure | 2 | 2007 | 53 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1015 | 0.070 |
Why?
|
| Syndrome | 1 | 2007 | 446 | 0.070 |
Why?
|
| Foreign Bodies | 1 | 2007 | 63 | 0.070 |
Why?
|
| Inflammation | 1 | 2012 | 923 | 0.070 |
Why?
|
| Incidence | 3 | 2013 | 1578 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 32 | 0.070 |
Why?
|
| Vena Cava, Inferior | 1 | 2007 | 143 | 0.070 |
Why?
|
| Aneurysm, Ruptured | 1 | 2006 | 51 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2009 | 265 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 195 | 0.070 |
Why?
|
| Bacteremia | 1 | 2006 | 99 | 0.070 |
Why?
|
| Prenatal Diagnosis | 2 | 2009 | 104 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2009 | 152 | 0.060 |
Why?
|
| Ebstein Anomaly | 1 | 2004 | 5 | 0.060 |
Why?
|
| Stroke | 1 | 2013 | 965 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2013 | 1010 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 255 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1802 | 0.060 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2003 | 87 | 0.060 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 190 | 0.050 |
Why?
|
| Pericardium | 1 | 2003 | 65 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 1052 | 0.050 |
Why?
|
| Pacemaker, Artificial | 1 | 2003 | 87 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2022 | 60 | 0.050 |
Why?
|
| Gases | 1 | 2022 | 30 | 0.050 |
Why?
|
| Autopsy | 2 | 2014 | 116 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2003 | 166 | 0.050 |
Why?
|
| Aortic Valve | 1 | 2003 | 222 | 0.050 |
Why?
|
| Reoperation | 2 | 2003 | 597 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 361 | 0.050 |
Why?
|
| Arkansas | 2 | 2010 | 2 | 0.050 |
Why?
|
| Young Adult | 2 | 2009 | 5980 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 208 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2000 | 303 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2000 | 232 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1239 | 0.040 |
Why?
|
| Pregnancy | 2 | 2009 | 2894 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2014 | 374 | 0.040 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1998 | 16 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2000 | 290 | 0.040 |
Why?
|
| Thrombosis | 1 | 2000 | 296 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 726 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 1169 | 0.040 |
Why?
|
| Aortopulmonary Septal Defect | 1 | 1996 | 1 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 1566 | 0.030 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1996 | 38 | 0.030 |
Why?
|
| Age Factors | 1 | 2000 | 1852 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2015 | 56 | 0.030 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 1 | 1994 | 3 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1996 | 165 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1994 | 34 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 3362 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1994 | 167 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2014 | 76 | 0.030 |
Why?
|
| Hyperbilirubinemia | 1 | 1993 | 20 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 1993 | 72 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2012 | 4214 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2013 | 278 | 0.030 |
Why?
|
| Hip | 1 | 2012 | 18 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 72 | 0.030 |
Why?
|
| Rotation | 1 | 2012 | 89 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1994 | 435 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 34 | 0.030 |
Why?
|
| Adult | 2 | 2009 | 25659 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2014 | 268 | 0.030 |
Why?
|
| Body Height | 1 | 2012 | 99 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2012 | 63 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2012 | 151 | 0.020 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 2010 | 2 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 422 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 459 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 376 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2010 | 131 | 0.020 |
Why?
|
| Child Development | 1 | 2012 | 163 | 0.020 |
Why?
|
| Photography | 1 | 2010 | 37 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 1961 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2012 | 290 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 111 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 73 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2009 | 44 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 840 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2009 | 90 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 286 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2010 | 298 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2009 | 100 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 364 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 684 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 778 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2009 | 152 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2009 | 276 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1824 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2009 | 247 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 752 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2006 | 63 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1532 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2706 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2003 | 6 | 0.010 |
Why?
|
| Washington | 1 | 2003 | 48 | 0.010 |
Why?
|
| Tricuspid Atresia | 1 | 2003 | 4 | 0.010 |
Why?
|
| Pulmonary Valve | 1 | 2003 | 32 | 0.010 |
Why?
|
| Child Welfare | 1 | 2003 | 39 | 0.010 |
Why?
|
| Heart Septal Defects | 1 | 2003 | 31 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 2003 | 74 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 197 | 0.010 |
Why?
|
| Morbidity | 1 | 2003 | 148 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2003 | 109 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2003 | 171 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2003 | 331 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2003 | 119 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 2504 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 2216 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2003 | 248 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2003 | 996 | 0.010 |
Why?
|
| Brimonidine Tartrate | 1 | 1994 | 1 | 0.010 |
Why?
|
| Prazosin | 1 | 1994 | 9 | 0.010 |
Why?
|
| Yohimbine | 1 | 1994 | 7 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 18 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1994 | 45 | 0.010 |
Why?
|
| Quinoxalines | 1 | 1994 | 50 | 0.010 |
Why?
|
| Arginine | 1 | 1994 | 136 | 0.010 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1993 | 18 | 0.010 |
Why?
|
| Swine | 1 | 1994 | 555 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1994 | 278 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2003 | 2207 | 0.010 |
Why?
|
| Portal Vein | 1 | 1993 | 120 | 0.010 |
Why?
|
| Animals | 1 | 1994 | 26590 | 0.000 |
Why?
|